Enterprise Linux Today: Inpharmatica installs largest European commercial bioinformatics processor platformDec 13, 2000, 20:22 (0 Talkback[s])
"1,100 Linux processor configuration combines unique software and operational IT techniques with world-leading science to accelerate drug discovery through the analysis of protein structures."
"Inpharmatica, a leading innovator in the application of structural bioinformatics in pharmaceutical research, announced today that it has more than doubled the power of its in-house computer facilities. Correctly-used computer power is an essential part of present and future techniques involved in discovering the drugs of tomorrow and in analysing the enormous amounts of data now generated by the Human Genome Project. Inpharmatica's 1,100 processor system is the most powerful commercial installation in Europe dedicated to bioinformatics, the use of computer techniques in drug discovery."
"This substantial upgrade propels Inpharmatica into an even stronger position in the provision of up-to-date, comprehensive and, above all, useful information on the human proteome," said Dr Malcolm Weir, CEO at Inpharmatica. "Our Biopendium information resource that relates protein sequences to their structure and function is now able to incorporate all available genome sequence data for analysis. We can update it more frequently and carry out more and better customized projects for our clients."
"Historically, companies wanting to do large scale processing-intensive computing have had to rely on specialist high performance computing vendors with high-cost proprietary solutions," said Pat Leach, IT director at Inpharmatica. "The use of Linux and the low cost of standard PC components has enabled Inpharmatica to achieve `more for less'."